Literature DB >> 16847389

Frequency of headache and migraine in Qatar.

Abdulbari Bener1.   

Abstract

BACKGROUND: Headache is a worldwide problem that affects all ages. To date there are no epidemiological data regarding headaches in Qatar. AIM: The aim of this study was to use the International Headache Society (IHS) diagnostic criteria to estimate the prevalence of migraine and headache in an adult population.
DESIGN: This is a cross-sectional population-based study.
SETTING: The study was carried out at 12 Primary Health Care Centers during the period from October to December 2004 in Qatar.
SUBJECTS: Of the 1,200 subjects who were approached to participate in this study, 913 gave their consent, representing a response rate of 76.1%.
METHODS: Subjects were selected by a multistage stratified sampling procedure. We used the IHS criteria for migraine. Face-to-face interviews were based on a questionnaire that included variables such as age, sex, socioeconomic status, lifestyle habits, exacerbating factors, warning symptoms, associated features, family history and associated factors.
RESULTS: Of the studied subjects, 54.9% were males and 45.1% females. The prevalence of headache and migraine among men was 67.9%, 7.8%, and among women 78.2%, 8.0%, respectively. Subjects aged 25-34 years had higher prevalence of headache comparing to other age groups (27.3%). Prevalence of headache was higher in women. Subjects with less than a high school education had higher frequency of headache (49.1%). The most common warning symptoms prior to headache were abnormal vision (53.0%) and weakness (30.4%). Stress (71.8%) and weather (49.5%) made headache worse in subjects. The majority of the headache sufferers looked for a dark (33.7%) and quiet place (74.5%) to rest.
CONCLUSION: Headachedisorders constitute a public health problem in a newly developed Qatari society, due to fast urbanization. More women suffered from headache and migraine than men. The study revealed that there was a strong association between hemoglobin level and headache and its severity. Furthermore, the prevalence of headache and migraine in Qatar is higher than in Western and African countries.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16847389     DOI: 10.1159/000094579

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  7 in total

1.  Prevalence of migraine and tension-type headache among adults in Jordan.

Authors:  Karem H Alzoubi; Nizar Mhaidat; Sayer Al Azzam; Yousef Khader; Saad Salem; Hanin Issaifan; Rania Haddadin
Journal:  J Headache Pain       Date:  2009-04-23       Impact factor: 7.277

2.  Primary headache in yemen: prevalence and common medications used.

Authors:  Salah A Abdo; Mohammed Amood Al-Kamarany; Karem H Alzoubi; Mohamed T Al-Maktari; Abdulrhman H Al-Baidani
Journal:  Neurol Res Int       Date:  2014-11-05

3.  Burden of migraine in a Kuwaiti population: a door-to-door survey.

Authors:  Jasem Yousef Al-Hashel; Samar Farouk Ahmed; Raed Alroughani
Journal:  J Headache Pain       Date:  2017-10-13       Impact factor: 7.277

4.  The Epidemiology of Migraine Headache in Arab Countries: A Systematic Review.

Authors:  Ashraf El-Metwally; Paivi Toivola; Khalid AlAhmary; Salwa Bahkali; Ali AlKhathaami; Shatha A Al Ammar; Ibrahim M Altamimi; Saleh M Alosaimi; Munazza Jawed; Sami Almustanyir
Journal:  ScientificWorldJournal       Date:  2020-06-16

Review 5.  Epidemiology of headache in Arab countries.

Authors:  Hani T S Benamer; Dirk Deleu; Donald Grosset
Journal:  J Headache Pain       Date:  2009-12-01       Impact factor: 7.277

6.  Migraine among medical students in Kuwait University.

Authors:  Jasem Y Al-Hashel; Samar Farouk Ahmed; Raed Alroughani; Peter J Goadsby
Journal:  J Headache Pain       Date:  2014-05-10       Impact factor: 7.277

7.  Longitudinal Modeling of Non-Pharmacological Factors Related to Frequency, Severity and Duration in Both Migraine and Tension-Type Headaches.

Authors:  Somaye Hosseini; Reyhaneh Rikhtehgaran; Mohammad Saadatnia; Alireza Zandifar; Marjan Mansourian
Journal:  J Res Health Sci       Date:  2020-10-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.